Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

Investor Presentation

Read Now


Our Pipeline

Learn More
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

November 26, 2019

BeiGene to Present at the 31st Annual Piper Jaffray Healthcare Conference

November 23, 2019

BeiGene Announces Clinical Data on Tislelizumab Presented at European Society for Medical Oncology (ESMO) Asia 2019 Congress

November 14, 2019

U.S. FDA Grants BeiGene’s BRUKINSA™ (zanubrutinib) Accelerated Approval to Treat Adult Patients with Mantle Cell Lymphoma Who Received at Least One Prior Therapy

Key Metrics

Key Metrics

  • 3,000


  • 1,000+

    Clinical team

  • 4


This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.